Shares of CVS Health Corporation (NYSE:CVS) were down 2.9% during trading on Thursday . The stock traded as low as $94.31 and last traded at $94.40, with a volume of 4,502,111 shares. The stock had previously closed at $97.17.

A number of analysts have recently weighed in on the stock. Credit Suisse Group AG restated a “buy” rating and issued a $115.00 target price on shares of CVS Health Corporation in a report on Sunday, June 5th. Morgan Stanley restated a “hold” rating and issued a $104.00 target price on shares of CVS Health Corporation in a report on Wednesday, August 3rd. Jefferies Group restated a “buy” rating on shares of CVS Health Corporation in a report on Monday, July 4th. FBR & Co restated an “outperform” rating and issued a $120.00 target price on shares of CVS Health Corporation in a report on Wednesday, August 3rd. Finally, Citigroup Inc. boosted their target price on shares of CVS Health Corporation from $105.00 to $115.00 and gave the stock a “neutral” rating in a report on Monday, May 9th. Six research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $113.02.

The company has a market cap of $99.44 billion and a price-to-earnings ratio of 21.45. The stock’s 50-day moving average price is $96.36 and its 200 day moving average price is $98.52.

CVS Health Corporation (NYSE:CVS) last announced its quarterly earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.30 by $0.02. The company had revenue of $43.70 billion for the quarter, compared to analyst estimates of $44.28 billion. During the same quarter in the prior year, the business earned $1.19 earnings per share. CVS Health Corporation’s revenue was up 17.6% on a year-over-year basis. Equities research analysts expect that CVS Health Corporation will post $5.86 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Monday, August 1st. Shareholders of record on Thursday, July 21st were given a dividend of $0.425 per share. This represents a $1.70 dividend on an annualized basis and a dividend yield of 1.82%. The ex-dividend date of this dividend was Tuesday, July 19th.

Several large investors recently made changes to their positions in the stock. Sawtooth Asset Management Inc. boosted its stake in shares of CVS Health Corporation by 96.0% in the fourth quarter. Sawtooth Asset Management Inc. now owns 10,624 shares of the pharmacy operator’s stock worth $1,039,000 after buying an additional 5,203 shares in the last quarter. Tributary Capital Management LLC boosted its position in shares of CVS Health Corporation by 5.3% in the fourth quarter. Tributary Capital Management LLC now owns 12,000 shares of the pharmacy operator’s stock worth $1,173,000 after buying an additional 600 shares during the period. American National Bank & Trust Co. VA boosted its position in shares of CVS Health Corporation by 2.3% in the fourth quarter. American National Bank & Trust Co. VA now owns 20,823 shares of the pharmacy operator’s stock worth $2,036,000 after buying an additional 471 shares during the period. Weatherly Asset Management L. P. boosted its position in shares of CVS Health Corporation by 3.2% in the fourth quarter. Weatherly Asset Management L. P. now owns 21,881 shares of the pharmacy operator’s stock worth $2,139,000 after buying an additional 678 shares during the period. Finally, Karp Capital Management Corp boosted its position in shares of CVS Health Corporation by 380.1% in the fourth quarter. Karp Capital Management Corp now owns 26,378 shares of the pharmacy operator’s stock worth $2,579,000 after buying an additional 20,884 shares during the period.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.